New basis for product differentiation
"This service fills the single largest untapped value opportunity in the industry!"
For the pharmaceutical industry, the medAmigo service offers a range of benefits, starting with relationship building and brand building. It gives an opportunity to differentiate a drug from a competitor. The medAmigo service gives unique help to caregivers, by efficiently providing reliable data on each patient’s drug dosing history, thereby discriminating between noncompliance and pharmacological nonresponse as the basis for unsatisfactory responses to prescribed medicines.
The confident recognition of nonadherence-based failure of treatment dispels prescribers’ doubts about the product’s effectiveness. Patients benefit, too, because reliable dosing history data are a uniquely powerful tool for confident management that can bring adherence up to a level which assures that the patient gets the fullest possible benefit from the treatment. For the drug manufacturer, sound management of the patient’s dosing focuses on, and achieves, the patient’s long persistence with the drug dosing regimen. Reliable dosing history data confirms the effectiveness of the medAmigo service and need for fine-tuning.
Extending persistence reduces costly ‘churn’, whereby early dropouts from treatment have constantly to be replaced in order just to keep the sales level constant. When those same sales efforts continue in the face of long-extended persistence, sales and profits rise to unprecedented heights, unmasking the hidden blockbusters that are ordinarily lost to high rates of ‘churn’.
